ConductScience.org, home

Gene · 5919

RARRES2: retinoic acid receptor responder 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RARRES2: retinoic acid receptor responder 2. Genes, record 5919. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5919

On this page

Gene

Symbol
RARRES2
HGNC
Name
retinoic acid receptor responder 2
HGNC
NCBI Gene ID
5919
NCBI Gene
HGNC ID
HGNC:9868
HGNC
Ensembl
ENSG00000106538
NCBI Gene
Aliases
HP10433, TIG2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q99969Retinoic acid receptor responder protein 216312Ensembl, GeneID, HGNC

Source UniProt

Patents105

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705329 A12026-03-1112Q99969Espacenet
JP 2026004568 A2026-01-1461516Q99969Espacenet
JP 2026004568 A2026-01-1461517Q99969Espacenet
JP 2026004568 A2026-01-1461518Q99969Espacenet
EP 4650780 A22025-11-19592Q99969Espacenet
JP 2025147176 A2025-10-0611244Q99969Espacenet
JP 2025147176 A2025-10-0611245Q99969Espacenet
JP 2025147176 A2025-10-0611246Q99969Espacenet
JP 2025529142 A2025-09-047526Q99969Espacenet
US 12371689 B22025-07-297526Q99969Espacenet

1 to 10 of 105

See all 105 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants908

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRARRES2 papersNewest fiscal year
R01AI047822Intestinal Lymphocyte Trafficking92025
T32AI007290Molecular and Cellular Immunobiology92025
P30DK040561Boston Area Nutrition Obesity Research Center (NORC)52025
I01BX004115New Approaches to Combat CNS Inflammation: Targeting a Metabolic Enzyme in Demyelinating Disease32025
P30CA016672Cancer Center Support Grant32025
UL1TR001863Yale Clinical and Translational Science Award32025
P30CA016058Cancer Center Support Grant22025
P30DK017047Diabetes Research Center22025
P30DK020572Michigan Diabetes Research Center (MDRC)22025
P30DK116074Stanford Diabetes Research Center22025

1 to 10 of 908Source NIH's project files

See all 908 nih grants

Papers2,728

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in salt-sensitive hypertension.Clin Exp Hypertens202642802577PubTator, text miningPubMed
Effects of High-Intensity Interval Versus Moderate-Intensity Continuous Training in Adults with Prediabetes: A Single-Blind Randomized Controlled Trial.J Clin Med202642796049PubTator, text miningPubMed
Chemerin and Arterial Stiffness in the Brisighella Heart Study: A Residual-Based Discordance Analysis.Int J Mol Sci202642794691PubTator, text miningPubMed
Immunometabolic Biomarkers in Colorectal Cancer: An Exploratory Diagnostic Evaluation of PBEF/NAMPT, Chemerin, and Osteopontin.Int J Mol Sci202642794507PubTator, text miningPubMed
Tissue-Specific Chemerin in Atherosclerosis.Biomolecules202642793159PubTator, text miningPubMed
Serum Endothelin-1 in Suspected Acute Pulmonary Embolism: A Prospective Study.J Cardiovasc Dev Dis202642783055PubTator, text miningPubMed
Adipokines in preeclampsia: Pathophysiological insights and biomarker potential.Cytokine202642735512PubTator, text miningPubMed
Biomarkers in plasma and extracellular vesicles for early detection of asymptomatic ischemic heart disease: a retrospective case-control study.Cardiovasc Diagn Ther202642719294PubTator, text miningPubMed
Tazarotene-Induced Gene 2 Promotes Melanoma Cell Death via the Activation of Endoplasmic Reticulum Stress.Front Biosci (Landmark Ed)202642689973PubTator, text miningPubMed
Serum Chemerin Concentrations and Tissue Immunoreactivity in Colorectal Adenoma and Colorectal Cancer: An Exploratory Case-Control Study.Diagnostics (Basel)202642650992PubTator, text miningPubMed

1 to 10 of 2,728

See all 2,728 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/5919

GET https://conductscience.org/api/genes/v1/5919/patents?page=2